Millennium Management’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-212,298
Closed -$1.05M 6335
2025
Q1
$1.05M Buy
212,298
+163,533
+335% +$520K ﹤0.01% 4304
2024
Q4
$143K Sell
48,765
-104,792
-68% -$430K ﹤0.01% 5404
2024
Q3
$725K Sell
153,557
-321,528
-68% -$1.45M ﹤0.01% 4533
2024
Q2
$1.83M Sell
475,085
-200,348
-30% -$903K ﹤0.01% 3606
2024
Q1
$3.61M Sell
675,433
-1,659,839
-71% -$7.81M ﹤0.01% 3205
2023
Q4
$9.97M Sell
2,335,272
-1,313,893
-36% -$4.04M ﹤0.01% 2187
2023
Q3
$14.3M Buy
3,649,165
+753,689
+26% +$4.94M 0.01% 1715
2023
Q2
$29.3M Buy
2,895,476
+952,858
+49% +$10.1M 0.01% 1086
2023
Q1
$19.8M Buy
1,942,618
+577,227
+42% +$6.6M 0.01% 1341
2022
Q4
$12.8M Buy
1,365,391
+598,734
+78% +$8.45M 0.01% 1868
2022
Q3
$11.2M Buy
766,657
+233,786
+44% +$3.47M 0.01% 2003
2022
Q2
$7.03M Buy
532,871
+176,909
+50% +$2.41M ﹤0.01% 2453
2022
Q1
$6.07M Buy
355,962
+258,123
+264% +$4.38M ﹤0.01% 2717
2021
Q4
$2.51M Buy
+97,839
New +$3.05M ﹤0.01% 3557

Other funds holding TSVT

Millennium Management's TSVT Position: Q2 2025 in Review

Millennium Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 212,298 shares — an estimated $1.05M sold.

Millennium Management first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $29.3M in Q2 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Millennium Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Millennium Management sold 212,298 2seventy bio shares in Q2 2025, an estimated $1.05M.
  • Millennium Management first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Millennium Management's 2seventy bio position peaked at $29.3M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.